Because transcutaneous electrical nerve stimulation (TENS) works by reducing central excitability and activating central inhibition pathways, we tested the hypothesis that TENS would reduce pain and fatigue and improve function and hyperalgesia in people with fibromyalgia who have enhanced central excitability and reduced inhibition. The current study used a double-blinded randomized, placebo-controlled crossover design to test the effects of a single treatment of TENS with people with fibromyalgia. Three treatments were assessed in random order: active TENS, placebo TENS and no TENS. The following measures were assessed before and after each TENS treatment: pain and fatigue at rest and in movement; pressure pain thresholds, 6-m walk test, range of motion; 5-time sit-to-stand test, and single-leg stance. Conditioned pain modulation was completed at the end of testing. There was a significant decrease in pain and fatigue with movement for active TENS compared to placebo and no TENS. Pressure pain thresholds increased at the site of TENS (spine) and outside the site of TENS (leg) when compared to placebo TENS or no TENS. During active TENS, conditioned pain modulation was significantly stronger compared to placebo TENS and no TENS. No changes in functional tasks were observed with TENS. Thus, the current study suggests TENS has short-term efficacy in relieving symptoms of fibromyalgia while the stimulator is active. Future clinical trials should examine the effects of repeated daily delivery of TENS, similar to the way in which TENS is used clinically on pain, fatigue, function, and quality of life in individuals with fibromyalgia. Ó
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Introduction
The American College of Rheumatology classifies fibromyalgia (FM) as a clinical syndrome defined by chronic widespread muscle pain, fatigue and tenderness, with hyperalgesia to pressure over tender points [68] . Pain and fatigue associated with FM can interfere with daily function, work and social activities [1] . The cause of FM is unknown, but it is generally accepted that there is enhanced central excitability [47, [59] [60] [61] and reduced pain inhibition [26, 28, 32, 59, 61] . Thus, one of the main treatments for patients with FM must focus on pain relief to allow those patients to function more independently, both at home and at work. Research into the treatment of FM has demonstrated strong evidence that aerobic cardiovascular exercise improves symptoms of FM and improves quality of life [5] . However, exercise itself may be painful, and the increase in pain may potentially prevent patients from exercising [25, 57, 66] . Thus, treatments aimed at decreasing pain during movement should improve patients' abilities to participate in activities of daily living. Transcutaneous electrical nerve stimulation (TENS) is a nonpharmacological treatment modality that delivers electrical stimulation through the skin and is used for control of both acute and chronic pain [2, 9, 10, 15, 46, 49, 51, 67] .
TENS activates central inhibitory pathways [8, 23, 37, 52] and decreases central excitability [23, 34, 36, 53, 55] . TENS activates descending inhibitory pathways from the midbrain and brainstem to inhibit excitability of nociceptive neurons in the spinal cord. Although TENS is shown to be effective for several pain conditions, such as osteoarthritis, chronic musculoskeletal pain and postoperative pain [4, 20, 45] , its effectiveness in treatment of people with
